 |
|
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Mark Olfson, MD, MPH;
Carlos Blanco, MD, PhD;
Linxu Liu, PhD;
Carmen Moreno, MD;
Gonzalo Laje, MD
Arch Gen Psychiatry. 2006;63:679-685.
Context Although there are indications that antipsychotic drugs are increasingly used to treat children and adolescents, little is known about the characteristics of those who receive them.
Objective To examine national trends and patterns in antipsychotic treatment of youth seen by physicians in office-based medical practice.
Design Analysis of national trends of visits (1993-2002) that included prescription of antipsychotics, and comparison of the clinical and demographic characteristics of visits (2000-2002) that included or did not include antipsychotic treatment.
Setting Outpatient visits to physicians in office-based practice.
Participants Patient visits by persons 20 years and younger from the National Ambulatory Medical Care Surveys from 1993 to 2002.
Main Outcome Measures Visits that included prescription of antipsychotics.
Results In the United States, the estimated number of office-based visits by youth that included antipsychotic treatment increased from approximately 201 000 in 1993 to 1 224 000 in 2002. From 2000 to 2002, the number of visits that included antipsychotic treatment was significantly higher for male youth (1913 visits per 100 000 population) than for female youth (739 visits per 100 000 population), and for white non-Hispanic youth (1515 visits per 100 000 population) than for youth of other racial or ethnic groups (426 visits per 100 000 population). Overall, 9.2% of mental health visits and 18.3% of visits to psychiatrists included antipsychotic treatment. From 2000 to 2002, 92.3% of visits with prescription of an antipsychotic included a second-generation medication. Mental health visits with prescription of an antipsychotic included patients with diagnoses of disruptive behavior disorders (37.8%), mood disorders (31.8%), pervasive developmental disorders or mental retardation (17.3%), and psychotic disorders (14.2%).
Conclusions There has been a sharp national increase in antipsychotic treatment among children and adolescents in office-based medical practice. Second-generation antipsychotics are being widely prescribed, and emerging empirical evidence provides a base of support that is limited to short-term safety and efficacy.
Author Affiliations: New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons (Drs Olfson, Blanco, Liu, and Moreno), and Department of Biostatistics, Mailman School of Public Health (Dr Liu), Columbia University, New York; and Genetic Basis of Mood and Anxiety Disorders, Mood and Anxiety Program, National Institute of Mental Health, Bethesda, Md (Dr Laje).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Who Are the New Users of Antipsychotic Medications?
Domino and Swartz
Psychiatr. Serv. 2008;59:507-514.
ABSTRACT
| FULL TEXT
Use of Antipsychotic Drugs Among Dutch Youths Between 1997 and 2005
Kalverdijk et al.
Psychiatr. Serv. 2008;59:554-560.
ABSTRACT
| FULL TEXT
A Preliminary Attempt to Personalize Risperidone Dosing Using Drug-Drug Interactions and Genetics: Part I
de Leon et al.
Psychosomatics 2008;49:258-270.
ABSTRACT
| FULL TEXT
Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom
Rani et al.
Pediatrics 2008;121:1002-1009.
ABSTRACT
| FULL TEXT
Incarceration and Psychotropic Drug Use by Youth
Cuellar et al.
Arch Pediatr Adolesc Med 2008;162:219-224.
ABSTRACT
| FULL TEXT
Bibliography Schizophrenia
Focus 2008;6:197-199.
FULL TEXT
Abstracts
Focus 2008;6:200-204.
FULL TEXT
Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY
James
Adv. Psychiatr. Treat. 2008;14:10-16.
ABSTRACT
| FULL TEXT
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Tohen et al.
Am. J. Psychiatry 2007;164:1547-1556.
ABSTRACT
| FULL TEXT
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Moreno et al.
Arch Gen Psychiatry 2007;64:1032-1039.
ABSTRACT
| FULL TEXT
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Polinski et al.
Health Aff (Millwood) 2007;26:750-760.
ABSTRACT
| FULL TEXT
Risperidone (Risperdal)
JWatch Pediatrics 2007;2007:4-4.
FULL TEXT
Gaining: Pediatric Patients and Use of Atypical Antipsychotics
Towbin
Am. J. Psychiatry 2006;163:2034-2036.
FULL TEXT
Risperidone maintenance treatment increases time to symptom recurrence in young people with disruptive behaviour disorders.
Vitiello
Evid. Based Ment. Health 2006;9:105-105.
FULL TEXT
Pediatric Antipsychotic Prescription Rates Soar
Schonwald
AAP Grand Rounds 2006;16:25-26.
FULL TEXT
Increasing Use of Second-Generation Antipsychotics in Children and Adolescents
JWatch Pediatrics 2006;2006:1-1.
FULL TEXT
Rational prescribing for children.
Sutcliffe and Wong
BMJ 2006;332:1464-1465.
FULL TEXT
Pediatric Treatment with Antipsychotic Drugs
JWatch Psychiatry 2006;2006:1-1.
FULL TEXT
Antipsychotic use among US young people has risen sixfold.
Tanne
BMJ 2006;332:1407-1407.
FULL TEXT
|
